We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROO icon
8526
TROOPS Inc
TROO
$202M
$15K ﹤0.01%
+13,036
New +$14.9K
HURA
8527
TuHURA Biosciences
HURA
$130M
$15K ﹤0.01%
1
ONCS
8528
DELISTED
OncoSec Medical Incorporated
ONCS
$15K ﹤0.01%
+49
New +$17.2K
WMGIZ
8529
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$15K ﹤0.01%
11,761
-25,657
-69% -$33.5K
ANW
8530
DELISTED
Aegean Marine Petroleum Network
ANW
$15K ﹤0.01%
22,773
-42,710
-65% -$94.5K
TIO
8531
DELISTED
Tingo Group, Inc. Common Stock
TIO
$15K ﹤0.01%
13,154
-21,904
-62% -$29.8K
KPRX icon
8532
Kiora Pharmaceuticals
KPRX
$11.4M
$14K ﹤0.01%
5
-5
-50% -$14.1K
NNVC icon
8533
NanoViricides
NNVC
$39.3M
$14K ﹤0.01%
+1,549
New +$19K
PTN
8534
Palatin Technologies
PTN
$14.4M
$14K ﹤0.01%
11
-128
-92% -$187K
RCON icon
8535
Recon Technology
RCON
$32.2M
$14K ﹤0.01%
+113
New +$13.6K
NBSE
8536
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$14K ﹤0.01%
172
+60
+54% +$5.24K
CFMS
8537
DELISTED
Conformis, Inc. Common Stock
CFMS
$14K ﹤0.01%
+468
New +$16.2K
LGC.WS
8538
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$14K ﹤0.01%
32,093
+2,493
+8% +$957
BORN
8539
DELISTED
China New Borun Corporation
BORN
$14K ﹤0.01%
11,215
-14,992
-57% -$19.3K
CPHI icon
8540
China Pharma Holdings
CPHI
$48.6M
$13K ﹤0.01%
122
-178
-59% -$24K
FTEK icon
8541
Fuel Tech
FTEK
$43M
$13K ﹤0.01%
11,957
+699
+6% +$862
IZEA icon
8542
IZEA Worldwide
IZEA
$58.7M
$13K ﹤0.01%
+3,418
New +$25K
BIOL
8543
DELISTED
Biolase, Inc.
BIOL
$13K ﹤0.01%
4
-3
-43% -$11.3K
NVCN
8544
DELISTED
Neovasc Inc.
NVCN
$13K ﹤0.01%
+12
New +$12.4K
GNCA
8545
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$13K ﹤0.01%
+1,963
New +$14.7K
VGZ icon
8546
Vista Gold
VGZ
$250M
$12K ﹤0.01%
17,954
-87,730
-83% -$62.5K
BETS
8547
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
RSYS
8548
CALL
DELISTED
Radisys Corp
RSYS
$12K ﹤0.01%
+17,200
New +$12.5K
NCTY
8549
The9 Ltd
NCTY
$66.6M
$11K ﹤0.01%
108
+64
+145% +$7.96K
PRPO icon
8550
Precipio
PRPO
$39.1M
$11K ﹤0.01%
+104
New +$13.9K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.